Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management.


Journal

Clinical and molecular hepatology
ISSN: 2287-285X
Titre abrégé: Clin Mol Hepatol
Pays: Korea (South)
ID NLM: 101586730

Informations de publication

Date de publication:
02 2023
Historique:
received: 05 11 2022
accepted: 20 12 2022
pubmed: 23 12 2022
medline: 16 3 2023
entrez: 22 12 2022
Statut: ppublish

Résumé

The prevalence of obesity and metabolic consequences such as nonalcoholic fatty liver diseases (NAFLD) has become a crucial health problem. Lifestyle modifications, especially weight loss, effectively reduces liver injury in NAFLD patients. However, adherence to lifestyle changes is very low in the clinical setting. Bariatric surgery can improve metabolic components and cause long-term weight loss. Therefore, bariatric surgery could serve as an attractive treatment option for NAFLD patients. This review integrates data about the benefits of bariatric surgery on NAFLD but also describes the potential pitfalls.

Identifiants

pubmed: 36545709
pii: cmh.2022.0373
doi: 10.3350/cmh.2022.0373
pmc: PMC10029945
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S276-S285

Subventions

Organisme : Research Foundation Flanders
ID : 12R0321N
Organisme : Research Foundation Flanders
ID : 1805718N

Références

Surg Obes Relat Dis. 2016 Aug;12(7):1391-1396
pubmed: 27012877
Obes Surg. 2020 Sep;30(9):3444-3452
pubmed: 32285332
Surg Obes Relat Dis. 2018 Oct;14(10):1607-1616
pubmed: 30146425
Gastroenterology. 2019 May;156(6):1627-1641.e1
pubmed: 30742833
PLoS Med. 2020 Jul 28;17(7):e1003206
pubmed: 32722673
N Engl J Med. 2007 Aug 23;357(8):753-61
pubmed: 17715409
Gastroenterol Rep (Oxf). 2020 Nov 24;9(3):252-256
pubmed: 34316375
Biomed Res Int. 2020 Apr 26;2020:5023157
pubmed: 32420347
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2317-2326.e4
pubmed: 34871812
Obes Surg. 2014 Aug;24(8):1126-35
pubmed: 25008469
Transplantation. 2019 Nov;103(11):e345-e354
pubmed: 31415032
Clin Mol Hepatol. 2022 Apr;28(2):196-206
pubmed: 35021598
Surg Obes Relat Dis. 2020 Sep;16(9):1336-1347
pubmed: 32694040
Lancet Diabetes Endocrinol. 2019 Mar;7(3):231-240
pubmed: 30704950
Liver Int. 2021 May;41(5):1012-1019
pubmed: 33529460
Surg Obes Relat Dis. 2008 Mar-Apr;4(2):159-64; discussion 164-5
pubmed: 18294923
J Clin Med. 2021 Aug 24;10(17):
pubmed: 34501231
Clin Mol Hepatol. 2021 Jul;27(3):363-401
pubmed: 34154309
J Hepatol. 2021 Aug;75(2):284-291
pubmed: 33746083
J Clin Med. 2020 Oct 26;9(11):
pubmed: 33114543
Obes Surg. 2020 Apr;30(4):1241-1248
pubmed: 31853866
JAMA. 2021 Nov 23;326(20):2031-2042
pubmed: 34762106
Obes Surg. 2023 Jan;33(1):284-292
pubmed: 36460941
Obes Rev. 2021 Sep;22(9):e13294
pubmed: 34002452
Obes Surg. 2015 Aug;25(8):1518-26
pubmed: 25982807
Clin Gastroenterol Hepatol. 2021 Mar;19(3):436-445
pubmed: 33393473
Hepatology. 2014 Jun;59(6):2188-95
pubmed: 24375711
Clin Mol Hepatol. 2020 Oct;26(4):383-400
pubmed: 32674529
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5
pubmed: 25865049
Hepatology. 2011 Aug;54(2):555-61
pubmed: 21567436
N Engl J Med. 2017 Feb 16;376(7):641-651
pubmed: 28199805
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
J Hepatol. 2019 Jan;70(1):172-193
pubmed: 30144956
Diabetes Obes Metab. 2017 Sep;19(9):1223-1232
pubmed: 28244626
PLoS One. 2014 Nov 06;9(11):e111808
pubmed: 25375228
Clin Gastroenterol Hepatol. 2022 Mar;20(3):511-524.e1
pubmed: 33727164
Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6
pubmed: 25917783
Clin Gastroenterol Hepatol. 2019 May;17(6):1040-1060.e11
pubmed: 30326299
Obes Surg. 2021 Jun;31(6):2817-2822
pubmed: 33486708
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):653-8
pubmed: 23701857
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
Transpl Int. 2018 Dec;31(12):1293-1317
pubmed: 30259574
Obes Surg. 2021 Mar;31(3):1214-1222
pubmed: 33225408
Obes Surg. 2016 Oct;26(10):2516-22
pubmed: 27381560
Surg Endosc. 2019 Aug;33(8):2521-2530
pubmed: 30350107
Obes Surg. 2017 Jun;27(6):1533-1542
pubmed: 27966066
JAMA. 2012 Jun 20;307(23):2516-25
pubmed: 22710289
Gastroenterology. 2020 Oct;159(4):1290-1301.e5
pubmed: 32553765
Transplant Proc. 2010 Dec;42(10):4395-8
pubmed: 21168706
Gastroenterology. 2019 Apr;156(5):1264-1281.e4
pubmed: 30660725
Hepatology. 2010 Jan;51(1):121-9
pubmed: 19827166
Obes Surg. 2016 Jan;26(1):177-81
pubmed: 26428254
J Hepatol. 2019 Nov;71(5):942-950
pubmed: 31330170
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):137-41
pubmed: 25701959
Clin Gastroenterol Hepatol. 2011 Oct;9(10):897-901
pubmed: 21782772
J Clin Endocrinol Metab. 2013 Apr;98(4):E708-12
pubmed: 23457410
Obes Surg. 2020 Dec;30(12):4899-4904
pubmed: 32996103
Surg Obes Relat Dis. 2019 Mar;15(3):502-511
pubmed: 30683512
Gastroenterology. 2021 Jul;161(1):171-184.e10
pubmed: 33744305
Obes Surg. 2020 Nov;30(11):4659-4664
pubmed: 32594466
Obes Surg. 2018 May;28(5):1342-1350
pubmed: 29119336
Liver Transpl. 2020 Jan;26(1):141-159
pubmed: 31610081

Auteurs

Anja Geerts (A)

Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Hepatology Research Unit, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Sander Lefere (S)

Hepatology Research Unit, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH